Global Inhaled Nitric Oxide Market Research Report 2023(Status and Outlook)

Global Inhaled Nitric Oxide Market Research Report 2023(Status and Outlook)



Report Overview

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.

North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.

In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.

The Global Inhaled Nitric Oxide Market Size was estimated at USD 1001.60 million in 2022 and is projected to reach USD 1750.22 million by 2029, exhibiting a CAGR of 8.30% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Inhaled Nitric Oxide market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Inhaled Nitric Oxide Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Inhaled Nitric Oxide market in any manner.

Global Inhaled Nitric Oxide Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Mallinckrodt

Praxair (Linde plc)

Air Liquide

BOC Healthcare (Linde Group)

Market Segmentation (by Type)

800 ppm

100 ppm

Others

Market Segmentation (by Application)

Traditional Pharmaceutical Industry

Biopharmaceutical Industry Industry

Academic & Research Institutes

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Inhaled Nitric Oxide Market

Overview of the regional outlook of the Inhaled Nitric Oxide Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Inhaled Nitric Oxide
1.2 Key Market Segments
1.2.1 Inhaled Nitric Oxide Segment by Type
1.2.2 Inhaled Nitric Oxide Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Inhaled Nitric Oxide Market Overview
2.1 Global Market Overview
2.1.1 Global Inhaled Nitric Oxide Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Inhaled Nitric Oxide Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Inhaled Nitric Oxide Market Competitive Landscape
3.1 Global Inhaled Nitric Oxide Sales by Manufacturers (2018-2023)
3.2 Global Inhaled Nitric Oxide Revenue Market Share by Manufacturers (2018-2023)
3.3 Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Inhaled Nitric Oxide Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Inhaled Nitric Oxide Sales Sites, Area Served, Product Type
3.6 Inhaled Nitric Oxide Market Competitive Situation and Trends
3.6.1 Inhaled Nitric Oxide Market Concentration Rate
3.6.2 Global 5 and 10 Largest Inhaled Nitric Oxide Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Inhaled Nitric Oxide Industry Chain Analysis
4.1 Inhaled Nitric Oxide Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Inhaled Nitric Oxide Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Inhaled Nitric Oxide Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inhaled Nitric Oxide Sales Market Share by Type (2018-2023)
6.3 Global Inhaled Nitric Oxide Market Size Market Share by Type (2018-2023)
6.4 Global Inhaled Nitric Oxide Price by Type (2018-2023)
7 Inhaled Nitric Oxide Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inhaled Nitric Oxide Market Sales by Application (2018-2023)
7.3 Global Inhaled Nitric Oxide Market Size (M USD) by Application (2018-2023)
7.4 Global Inhaled Nitric Oxide Sales Growth Rate by Application (2018-2023)
8 Inhaled Nitric Oxide Market Segmentation by Region
8.1 Global Inhaled Nitric Oxide Sales by Region
8.1.1 Global Inhaled Nitric Oxide Sales by Region
8.1.2 Global Inhaled Nitric Oxide Sales Market Share by Region
8.2 North America
8.2.1 North America Inhaled Nitric Oxide Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Inhaled Nitric Oxide Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Inhaled Nitric Oxide Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Inhaled Nitric Oxide Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Inhaled Nitric Oxide Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Mallinckrodt
9.1.1 Mallinckrodt Inhaled Nitric Oxide Basic Information
9.1.2 Mallinckrodt Inhaled Nitric Oxide Product Overview
9.1.3 Mallinckrodt Inhaled Nitric Oxide Product Market Performance
9.1.4 Mallinckrodt Business Overview
9.1.5 Mallinckrodt Inhaled Nitric Oxide SWOT Analysis
9.1.6 Mallinckrodt Recent Developments
9.2 Praxair (Linde plc)
9.2.1 Praxair (Linde plc) Inhaled Nitric Oxide Basic Information
9.2.2 Praxair (Linde plc) Inhaled Nitric Oxide Product Overview
9.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Product Market Performance
9.2.4 Praxair (Linde plc) Business Overview
9.2.5 Praxair (Linde plc) Inhaled Nitric Oxide SWOT Analysis
9.2.6 Praxair (Linde plc) Recent Developments
9.3 Air Liquide
9.3.1 Air Liquide Inhaled Nitric Oxide Basic Information
9.3.2 Air Liquide Inhaled Nitric Oxide Product Overview
9.3.3 Air Liquide Inhaled Nitric Oxide Product Market Performance
9.3.4 Air Liquide Business Overview
9.3.5 Air Liquide Inhaled Nitric Oxide SWOT Analysis
9.3.6 Air Liquide Recent Developments
9.4 BOC Healthcare (Linde Group)
9.4.1 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Basic Information
9.4.2 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Overview
9.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Market Performance
9.4.4 BOC Healthcare (Linde Group) Business Overview
9.4.5 BOC Healthcare (Linde Group) Inhaled Nitric Oxide SWOT Analysis
9.4.6 BOC Healthcare (Linde Group) Recent Developments
10 Inhaled Nitric Oxide Market Forecast by Region
10.1 Global Inhaled Nitric Oxide Market Size Forecast
10.2 Global Inhaled Nitric Oxide Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Inhaled Nitric Oxide Market Size Forecast by Country
10.2.3 Asia Pacific Inhaled Nitric Oxide Market Size Forecast by Region
10.2.4 South America Inhaled Nitric Oxide Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Inhaled Nitric Oxide by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Inhaled Nitric Oxide Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Inhaled Nitric Oxide by Type (2024-2029)
11.1.2 Global Inhaled Nitric Oxide Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Inhaled Nitric Oxide by Type (2024-2029)
11.2 Global Inhaled Nitric Oxide Market Forecast by Application (2024-2029)
11.2.1 Global Inhaled Nitric Oxide Sales (K MT) Forecast by Application
11.2.2 Global Inhaled Nitric Oxide Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings